Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

DURHAM, N.C. and BEIJING, March 30, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2022-03-30 08:05 2762

PolyU startup iMeddy provides free video medical consultation to COVID-19 patients to help fight the pandemic leveraging innovative technology

HONG KONG, March 24, 2022 /PRNewswire/ -- Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University (PolyU), known as iMeddy, is providing a free video medical consultation service on its pioneering online healthcare platform to a quo...

2022-03-24 20:29 1982

Early Detection Saves Lives: HPV Testing Kits - Chula's Innovation for Women's Health

BANGKOK, March 24, 2022 /PRNewswire/ -- Cervical cancer is the second most common cancer in Thai women age 30-60, after breast cancer, with 10,000 new cases per year, and claiming as many as 5,000 lives annually. Though curable if detected early, many women are afraid of getting tested due to the...

2022-03-24 08:15 3453

Early Detection Saves Lives: HPV Testing Kits - Chula's Innovation for Women's Health

Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

* First authorization of Novavax' COVID-19 vaccine in adolescent population received * Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorizedfor adolescents ≥12 to <18 inIndia * Authorization highligh...

2022-03-23 09:31 2666

Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results

– Advancing key programs in HBV, CNS, and HIV – – Received first BLA approval for COVID-19 Treatment in China and added to China's latest COVID-19 Diagnosis and Treatment Guidelines– – Multiple clinical value drivers expected across the portfolio in 2022 and beyond – – Cash, bank balances, an...

2022-03-23 07:20 3760

Cyclobenzaprine: positive opinion from EMA in Rapid Scientific Advice procedure as a possible anti-Covid-19 therapy

MILAN, March 22, 2022 /PRNewswire/ -- M-Squared Consulting, a consultancy company for life sciences companies in the management of pharmaceutical contracts, has received a first positive signal from EMA's Pandemic Task Force in the Rapid Scientific Advice1 procedure for potential treatments for C...

2022-03-22 22:12 1954

Bagging S$100,000 For The Second Time: How The Top Winners of #HuntTheMouse -- Safe Distancing Edition Did It

SINGAPORE, March 22, 2022 /PRNewswire/ -- A gold coin worth S$100,000 was found under the Skybridge at Queen's Close on 16 February,9.06pm. This coin had been hidden virtually in Sqkii's latest version of its well-loved hunt,#HuntTheMouse — Safe Distancing Edition (HTMSD), where the first person ...

2022-03-22 17:02 2744

Detecting COVID-19 using only a smartphone

* 92% sensitivity for detecting COVID-19 with a new cough audio-based algorithm BRISBANE, Australia, March 22, 2022 /PRNewswire/ -- ResApp Health Limited (ASX:RAP) today announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a smartphone. In an ...

2022-03-22 11:37 2021

Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules

SHIJIAZHUANG, China, March 21, 2022 /PRNewswire/ -- On March 19, the Media Briefing on Prevention and Control of COVID-19 with Lianhua Qingwen Capsules, a patented Chinese medicine developed and produced by Yiling Pharmaceutical, was convened inShijiazhuang City, Hebei Province, at which the in v...

2022-03-21 15:56 1918

Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules

BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University

VANCOUVER, BC, March 17, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has entered into an agreement with Millipore-Sigma ("Millipore") a global Contract Development and Manufacturing Research Organization (...

2022-03-17 20:18 3245

MGI Helps Combat COVID-19 Pandemic in Laos with Innovative Container Laboratory Thanks to the Support of LSEA

PAKSE, Laos, March 17, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a global life science leader and innovator, has developed Champa LSEA Laboratory, the first 3rd party detection center in Laos, under the support of the Belt and Road Life Science Economy Alliance (LSEA) and Sithandone Joint De...

2022-03-17 14:00 2468

Pasture Announces First Halal-Certified Surgical N95 Masks for Healthcare and Public Use

SINGAPORE, March 16, 2022 /PRNewswire/ -- Pasture Group, the leading global medical device manufacturer and pharmaceutical company inSingapore, unveils its accreditation as the world's top halal-certified US FDA-approved N95 mask producer for healthcare and public use.

2022-03-16 13:00 2289

Pasture Announces First Halal-Certified Surgical N95 Masks for Healthcare and Public Use

Brii Bio Announces that National Health Commission of China Adds Amubarvimab/Romlusevimab Combination to its COVID-19 Diagnosis and Treatment Guidelines (9th Pilot Edition)

The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, through a randomized, double-blind and placebo-controlled trial In vitro tests shows that amubarvimab/romlusevimab combination retains neutralizing activity against...

2022-03-16 09:00 2764

iGene Laboratory launches saliva-based COVID-19 PCR tests in Singapore

SINGAPORE, March 14, 2022 /PRNewswire/ -- In a move towards easing the uncomfortable nature of nasal swabs, a new saliva-based COVID-19 PCR test is now available at select iGene Laboratory partner clinics throughoutSingapore.

2022-03-14 16:39 2586

iGene Laboratory launches saliva-based COVID-19 PCR tests in Singapore

Arcc Spaces Shares That The Virtual Office Is A Good Working Solution for Small Businesses Beyond COVID-19

SINGAPORE, March 14, 2022 /PRNewswire/ -- Arcc Spaces , a pioneering flexible workspace service provider, shares its insights about hybrid work –the virtual office is becoming a growing trend, and is a good solution for small businesses and start-ups to cope wi...

2022-03-14 13:56 3182

Arcc Spaces Shares That The Virtual Office Is A Good Working Solution for Small Businesses Beyond COVID-19

Indonesia Ensures Strict Compliance with COVID-19 Protocol towards G20 Presidency

JAKARTA, Indonesia, March 14, 2022 /PRNewswire/ -- On track to host the G20 summit inBali on November 15-16, The Indonesia's Ministry of Health is set to implement a strict health protocol system as a precaution against COVID-19. The system will serve as a guideline for every in-person activity d...

2022-03-14 13:09 1580

Indonesia Puts Strict Health Protocols for G20 Summit, Highlights the Importance of Pandemic Preparedness

2022-03-14 13:09 2781

CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings

SHENZHEN, China, March 14, 2022 /PRNewswire/ -- CIMC Modular Building System will provide a total of 2,076 units of modular buildings to helpHong Kong fight against the COVID-19 pandemic. Modular transitional house being hoisted

2022-03-14 07:27 3277

CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings

Novavax Announces Launch of Global Vaccine Education Programs

- 'We Do Vaccines' and 'Know Our Vax' are new educational efforts that provide information regarding vaccines - Programs explain Novavax' commitment to vaccine development and innovation GAITHERSBURG, Md., March 10, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company de...

2022-03-10 22:00 3582

Novavax Announces Launch of Global Vaccine Education Programs

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families

HONG KONG, March 10, 2022 /PRNewswire/ -- In the face of the severe fifth wave of epidemic inHong Kong, Fosun Foundation quickly launched the epidemic relief work of "Let's Work Hand in Hand and Combat the Epidemic Together" inHong Kong. After the first batch of 250,000 sets of COVID-19 rapid ant...

2022-03-10 14:25 2659

Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families

1 ... 11 12 131415 16 17 ... 66